
SynBioBeta Speaker
Susan Klaeger
Principal Scientist
Genentech
May 2026, SynBioBeta
Speaker
Dr. Susan Klaeger is a Principal Scientist and Group Lead of Immunopeptidomics and Surface Proteomics at Genentech, a role she has held since 2022. Her research is focused on applied proteomics, specializing in immunopeptidomics and proteogenomics to discover and validate novel cancer antigens and biomarkers for therapeutic development. She holds a PhD from the Technical University of Munich and the German Cancer Consortium, where she applied chemoproteomics approaches to study selectivity of clinical kinase inhibitors, followed by a postdoctoral fellowship at The Broad Institute of MIT and Harvard, where her research focused on improving detection of MHC presented peptides, generation of large scale datasets for AI/ML approaches and proteogenomic integration to the discovery of MHC presented peptides derived from novel, unannotated open reading frames.
All Categories
SynBioBeta 2026 Tickets are Live
Confirmed Speakers
Conference Pass
1,995
USD
Save $1,000
Regular Rate
$2,995
Access to all 120+ Sessions
Attendee Directory
Networking Reception
1:1 Partnering App
1:1 Meeting Space
Lunch & Refreshments
Post Event Video Access
Price increases in
Purchase Pass
Purchase Pass
Cyber Week Deal
Buy 1 Conference Pass, Get 1 Expo Pass Free


Previous Speakers Include

Join for the latest
SynBioBeta event updates.




























































































































































































































































